Enveric Biosciences, Inc. · NASDAQ:ENVB
Enveric Biosciences, Inc. shareholders
As of Sep 30, 2026, 26 institutions reported holding Enveric Biosciences, Inc., 15.5% of its shares. Largest: Sio Capital Management, LLC, Ikarian Capital, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Enveric Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Sio Capital Management, LLC | 330K | 7.4% | +150K | Nov 16, 2026 |
| Ikarian Capital, LLC | 100K | 2.2% | no change | Nov 16, 2026 |
| Vanguard | 48,696 | 1.1% | +33,784 | Nov 13, 2026 |
| AdvisorShares Investments LLC | 43,783 | 0.98% | +8,366 | Nov 9, 2026 |
| Citadel | 41,372 | 0.92% | +27,407 | Nov 16, 2026 |
| Boothbay Fund Management, LLC | 30,142 | 0.67% | no change | Nov 16, 2026 |
| StoneX Group Inc. | 27,986 | 0.63% | +16,172 | Nov 3, 2026 |
| Jane Street | 19,444 | 0.43% | new | Nov 12, 2026 |
| Geode Capital | 17,794 | 0.40% | +6,000 | Nov 6, 2026 |
| XTX Topco Ltd | 13,366 | 0.30% | −5,624 | Nov 16, 2026 |